causal

CGMs Lower A1C by About 1.5 Points

Clinical trials show CGM use lowers A1C by about 1.5 percentage points, a difference that moves a patient from severe diabetes on a path to hospitalization to well controlled, delaying insulin treatment or hospitalization by years.

causalpending

Speaker

Aneal

Evidence Quote

“The use of CGMs has resulted in a decrease of A1C by about 1.5%.”

Source

Dexcom: Digitizing Diabetes Management— Business Breakdowns
Created: 11/20/2026, 5:18:27 AM

Your notes

Loading notes...